Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07726342 | SMP-656 for HER2-Positive Advanced Breast Cancer | not yet recruiting | Phase 2 | 60 | Chengdu SciMount Pharmatech Co., Ltd.INDUSTRY | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07606287 | Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital | not yet recruiting | N/A | 4,000 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jul 23, 2026 |
| clinicaltrials |
| NCT07683754 | T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd(DB-Guide) | not yet recruiting | Phase 3 | 200 | Daiichi SankyoINDUSTRY | 0 | Jul 23, 2026 | clinicaltrials |
| NCT07721259 | A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden | not yet recruiting | Phase 2 | 60 | University of WashingtonOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07722156 | The Effect of Channa Striata and Curcuma Supplementation on Nutritional Status, Interleukin-6 Levels, and Quality of Life in Patients With Breast Cancer.(CCBreast) | not yet recruiting | N/A | 76 | DINA KEUMALA SARIOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07186491 | Wearable Ultrasound Patch for Breast Imaging | not yet recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07490509 | Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer(DOSABEMA) | not yet recruiting | Phase 4 | 235 | Poitiers University HospitalOTHER | 0 | Jul 21, 2026 | clinicaltrials |
| NCT07716046 | Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer(FACET) | not yet recruiting | Phase 2 | 240 | Fudan UniversityOTHER | 0 | Jul 21, 2026 | clinicaltrials |
| NCT07716306 | Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer | not yet recruiting | N/A | 60 | Riga Stradins UniversityOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07717450 | Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.(TAILORswitch) | not yet recruiting | Phase 3 | 370 | UNICANCEROTHER | 0 | Jul 21, 2026 | clinicaltrials |
| NCT07706842 | Ataraxis Real-World Clinical Outcomes Registry Linking AI-Based Pathology Scores to Patient Outcomes(ARC) | not yet recruiting | — | 1,000 | Ataraxis AI, Inc.INDUSTRY | 0 | Jul 16, 2026 | clinicaltrials |
| NCT07706933 | Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast Cancer | not yet recruiting | N/A | 456 | Henan Cancer HospitalOTHER_GOV | 0 | Jul 16, 2026 | clinicaltrials |
| NCT07705074 | FAPI PET Imaging - An Exploratory Study(FAPIPET) | not yet recruiting | Phase 1 / Phase 2 | 770 | Martin HuellnerOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT07701018 | Advancing Patient Care for Lymphatic Pain and Lymphedema | not yet recruiting | N/A | 35 | University of Missouri, Kansas CityOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT07701070 | SHIELD: Surveillance of HR+/HER2- : Implementing ESR1m Long-term Monitoring and Detection in 1L aBC(SHIELD) | not yet recruiting | — | 3,000 | AstraZenecaINDUSTRY | 0 | Jul 14, 2026 | clinicaltrials |
| NCT05326165 | Early Intervention | not yet recruiting | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07695948 | Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer Survivors | not yet recruiting | Phase 3 | 252 | University of Illinois at ChicagoOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07697443 | Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects | not yet recruiting | Phase 1 / Phase 2 | 306 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07698314 | A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer(Myo-EXERTBC) | not yet recruiting | N/A | 21 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07681297 | Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease(TIBEC) | not yet recruiting | Phase 1 / Phase 2 | 154 | National University Hospital, SingaporeOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT07695415 | Network-Guided Theta Burst Stimulation for Breast Cancer With Chemotherapy-Induced Peripheral Neuropathy: Clinical and fMRI Biomarker Evidence(CIPN TBS) | not yet recruiting | N/A | 40 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT07696754 | Augmented-Reality ICG Fluorescence Second-Look for Residual Nodal Disease After Axillary Dissection in Breast Cancer(AR4SLN) | not yet recruiting | N/A | 30 | Ss. Cyril and Methodius University of SkopjeOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT07689721 | ctDNA-Guided Intraventricular Therapy for CNS Malignancies(GUIDE-CNS) | not yet recruiting | N/A | 77 | Alireza MansouriOTHER | 0 | Jul 8, 2026 | clinicaltrials |
| NCT07689929 | Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy | not yet recruiting | — | 900 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT07687225 | Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases(POSITIVE-Bone) | not yet recruiting | N/A | 216 | West China HospitalOTHER | 0 | Jul 7, 2026 | clinicaltrials |
| NCT07683572 | Device Validation of Augmented-Reality ICG Fluorescence Imaging for Sentinel Lymph Node Detection in Breast Cancer | not yet recruiting | — | 200 | Ss. Cyril and Methodius University of SkopjeOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07684456 | Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer | not yet recruiting | Phase 3 | 308 | Beijing Biostar Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07671937 | INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study(INSPIRE) | not yet recruiting | N/A | 2,748 | University of Alabama at BirminghamOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07229378 | Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer | not yet recruiting | N/A | 40 | University of FloridaOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07670754 | ORASIS in Breast Reconstruction | not yet recruiting | N/A | 30 | Duke UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07677956 | Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer | not yet recruiting | — | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Jul 1, 2026 | clinicaltrials |
| NCT07676344 | CRYO-TOUCH: Cryoablation of the Primary Breast Tumor in Metastatic Breast Cancer(CRYO-TOUCH) | not yet recruiting | N/A | 42 | Hospices Civils de LyonOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07676591 | EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors(EmpowerHer) | not yet recruiting | N/A | 147 | University of ValenciaOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07677436 | Effect of Virtual Reality-Guided Imagery on Pain, Anxiety, and Fatigue in Cancer Patients Undergoing Chemotherapy(VRGI-Chemo Tri) | not yet recruiting | N/A | 108 | Thoalfokar Mohammed Al-ObaidiOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07672431 | Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression | not yet recruiting | N/A | 24 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT07672743 | A Phase II Study of Radiation Therapy to Treat Refractory Breast Cancer | not yet recruiting | N/A | 29 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT07671690 | Prediction of Neoadjuvant Therapy Efficacy and Prognosis for Breast Cancer Based on Multimodal Data | not yet recruiting | N/A | 1,800 | Yunnan Cancer HospitalOTHER | 0 | Jun 26, 2026 | clinicaltrials |
| NCT07668362 | Prospective Cohort Study of Local Recurrence After Radical Breast Cancer Resection | not yet recruiting | — | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Jun 25, 2026 | clinicaltrials |
| NCT07669610 | An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Bevacizumab in First to Third Line BLIS Subtype TNBC(TRIBE) | not yet recruiting | Phase 3 | 140 | Fudan UniversityOTHER | 0 | Jun 25, 2026 | clinicaltrials |
| NCT07217990 | Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer(NoCUT-BC) | not yet recruiting | Phase 1 / Phase 2 | 84 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07665346 | A Pre-post Pilot of a Smartphone Intervention | not yet recruiting | N/A | 44 | University of VirginiaOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07581314 | Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC) | not yet recruiting | Phase 1 / Phase 2 | 76 | Telomir Pharmaceuticals, Inc.INDUSTRY | 0 | Jun 23, 2026 | clinicaltrials |
| NCT07662252 | Circulating Tumor DNA Dynamics to Optimize Neoadjuvant Therapy in HER2-Positive and Triple-Negative Breast Cancer(NEOSHED) | not yet recruiting | — | 186 | Federico II UniversityOTHER | 0 | Jun 23, 2026 | clinicaltrials |
| NCT07663006 | Breast and Cervical Cancer Stigma in Rwanda | not yet recruiting | N/A | 1,116 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07654257 | Single FrAction Interstitial BreaSt BracHytherApy(SASHA) | not yet recruiting | Phase 2 | 134 | Virginia Commonwealth UniversityOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07657442 | Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer | not yet recruiting | N/A | 649 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07658183 | A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer | not yet recruiting | Phase 2 | 120 | Shanghai Best-Link Bioscience, LLCINDUSTRY | 0 | Jun 18, 2026 | clinicaltrials |
| NCT07653698 | Cachexia and Gut Microbiota in Patients With Breast Cancer Receiving Home Care(GM_ANT) | not yet recruiting | N/A | 140 | Fondazione ANT Franco Pannuti ETSOTHER | 0 | Jun 17, 2026 | clinicaltrials |
| NCT07649902 | Artificial Intelligence Powered Digital Education Based on the Neuman Systems Model for Breast Cancer Patients Receiving Radiotherap | not yet recruiting | N/A | 38 | Ataturk UniversityOTHER | 0 | Jun 16, 2026 | clinicaltrials |
| NCT07644455 | Percutaneous Biopsy After Neoadjuvant Chemotherapy.(VAC-Biopsy) | not yet recruiting | N/A | 100 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Jun 12, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jul 24, 2026source: clinicaltrials